中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

9 records (took 0.021 seconds)

    6.
    发明专利
    未知

    公开(公告)号：NO922530L

    公开(公告)日：1992-12-28

    申请号：NO922530

    申请日：1992-06-26

    Applicant: GLAXO INC

    Inventor： MYERS PETER LESLIE ,  MCELROY ANDREW BRIAN ,  GREGSON MICHAEL ,  BROWN PETER JONATHAN ,  DAVIES HOWARD GEOFFREY ,  DREWRY DAVID HAROLD ,  FOLEY MICHAEL ANDREW

    IPC: A61K38/55 ,  A61K38/00 ,  A61P1/02 ,  A61P17/00 ,  A61P19/10 ,  A61P25/02 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D209/48 ,  C07D209/66 ,  C07D471/04 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07K1/06 ,  C07K1/113 ,  C07K5/02 ,  C07K5/06 ,  C07K5/08 ,  C07K5/10 ,  A61K37/64

    Abstract: Compounds are described of the formula wherein: R is C3-6alkyl or C1-3alkylthioC1-3alkyl; R is an optionally substituted C1-6alkyl or C1-6alkoxy group, aryl, heteroaryl, arylC1-4alkyl, heteroarylC1-4alkyl or a side-chain of a natural alpha -amino acid; R is hydrogen, C1-6alkyl, CHR COR (where R is a side-chain of a natural alpha -amino acid and R is hydroxyl, C1-6alkoxy or NHR where R represents a hydrogen atom or a C1-6alkyl group) or a group (CH2)nX (where n is 1 to 6 and X is hydroxyl, C1-4alkoxy, heteroaryl or a group NR R where R and R are each hydrogen or C1-6alkyl or the group NR R forms a 5 to 7 membered cyclic amine); and Het is an optionally substituted cyclic imide where the cyclic imide ring system has the formula (i), (ii) or (iii) in which A, B, C and D are each CH or 1 or 2 of A, B, C and D represents N and the others represent CH, and E and F may each independently represent CH or N; and physiologically acceptable salts and solvates thereof. These compounds inhibit metalloproteases involved in tissue degradation. Compounds of the invention may be formulated for use in a variety of conditions involving tissue degradation including arthropathy, dermatological conditions, bone resorption, inflammatory diseases, tumour invasion and multiple sclerosis and related diseases involving myelin degradation, and in the promotion of wound healing.

    7.
    发明专利
    未知

    公开(公告)号：FI922964A

    公开(公告)日：1992-12-28

    申请号：FI922964

    申请日：1992-06-26

    Applicant: GLAXO INC

    Inventor： MYERS PETER LESLIE ,  MCELROY ANDREW BRIAN ,  GREGSON MICHAEL ,  BROWN PETER JONATHAN ,  DAVIES HOWARD GEOFFREY ,  DREWRY DAVID HAROLD ,  FOLEY MICHAEL ANDREW

    IPC: A61K38/55 ,  A61K38/00 ,  A61P1/02 ,  A61P17/00 ,  A61P19/10 ,  A61P25/02 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D209/48 ,  C07D209/66 ,  C07D471/04 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07K1/06 ,  C07K1/113 ,  C07K5/02 ,  C07K5/06 ,  C07K5/08

    Abstract: Compounds are described of the formula wherein: R is C3-6alkyl or C1-3alkylthioC1-3alkyl; R is an optionally substituted C1-6alkyl or C1-6alkoxy group, aryl, heteroaryl, arylC1-4alkyl, heteroarylC1-4alkyl or a side-chain of a natural alpha -amino acid; R is hydrogen, C1-6alkyl, CHR COR (where R is a side-chain of a natural alpha -amino acid and R is hydroxyl, C1-6alkoxy or NHR where R represents a hydrogen atom or a C1-6alkyl group) or a group (CH2)nX (where n is 1 to 6 and X is hydroxyl, C1-4alkoxy, heteroaryl or a group NR R where R and R are each hydrogen or C1-6alkyl or the group NR R forms a 5 to 7 membered cyclic amine); and Het is an optionally substituted cyclic imide where the cyclic imide ring system has the formula (i), (ii) or (iii) in which A, B, C and D are each CH or 1 or 2 of A, B, C and D represents N and the others represent CH, and E and F may each independently represent CH or N; and physiologically acceptable salts and solvates thereof. These compounds inhibit metalloproteases involved in tissue degradation. Compounds of the invention may be formulated for use in a variety of conditions involving tissue degradation including arthropathy, dermatological conditions, bone resorption, inflammatory diseases, tumour invasion and multiple sclerosis and related diseases involving myelin degradation, and in the promotion of wound healing.

    8.
    发明专利
    未知

    公开(公告)号：NO922530D0

    公开(公告)日：1992-06-26

    申请号：NO922530

    申请日：1992-06-26

    Applicant: GLAXO INC

    Inventor： MYERS PETER LESLIE ,  MCELROY ANDREW BRIAN ,  GREGSON MICHAEL ,  BROWN PETER JONATHAN ,  DAVIES HOWARD GEOFFREY ,  DREWRY DAVID HAROLD ,  FOLEY MICHAEL ANDREW

    IPC: A61K38/55 ,  A61K38/00 ,  A61P1/02 ,  A61P17/00 ,  A61P19/10 ,  A61P25/02 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D209/48 ,  C07D209/66 ,  C07D471/04 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07K1/06 ,  C07K1/113 ,  C07K5/02 ,  C07K5/06 ,  C07K5/08 ,  C07K5/00

    Abstract: Compounds are described of the formula wherein: R is C3-6alkyl or C1-3alkylthioC1-3alkyl; R is an optionally substituted C1-6alkyl or C1-6alkoxy group, aryl, heteroaryl, arylC1-4alkyl, heteroarylC1-4alkyl or a side-chain of a natural alpha -amino acid; R is hydrogen, C1-6alkyl, CHR COR (where R is a side-chain of a natural alpha -amino acid and R is hydroxyl, C1-6alkoxy or NHR where R represents a hydrogen atom or a C1-6alkyl group) or a group (CH2)nX (where n is 1 to 6 and X is hydroxyl, C1-4alkoxy, heteroaryl or a group NR R where R and R are each hydrogen or C1-6alkyl or the group NR R forms a 5 to 7 membered cyclic amine); and Het is an optionally substituted cyclic imide where the cyclic imide ring system has the formula (i), (ii) or (iii) in which A, B, C and D are each CH or 1 or 2 of A, B, C and D represents N and the others represent CH, and E and F may each independently represent CH or N; and physiologically acceptable salts and solvates thereof. These compounds inhibit metalloproteases involved in tissue degradation. Compounds of the invention may be formulated for use in a variety of conditions involving tissue degradation including arthropathy, dermatological conditions, bone resorption, inflammatory diseases, tumour invasion and multiple sclerosis and related diseases involving myelin degradation, and in the promotion of wound healing.

    9.
    发明专利
    未知

    公开(公告)号：MX9203643A

    公开(公告)日：1995-01-31

    申请号：MX9203643

    申请日：1992-06-26

    Applicant: GLAXO INC

    Inventor： MYERS PETER LESLIE ,  MCELROY ANDREW BRIAN ,  GREGSON MICHAEL ,  BROWN PETER JONATHAN ,  DAVIES HOWARD GEOFREY ,  DREWRY DAVID HAROLD ,  FOLEY MICHAEL ANDREW

    IPC: A61K38/55 ,  A61K38/00 ,  A61P1/02 ,  A61P17/00 ,  A61P19/10 ,  A61P25/02 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D209/48 ,  C07D209/66 ,  C07D471/04 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07K1/06 ,  C07K1/113 ,  C07K5/02 ,  C07K5/06 ,  C07K5/08 ,  C07D209/00 ,  A61K31/395

    Abstract: Compounds are described of the formula wherein: R is C3-6alkyl or C1-3alkylthioC1-3alkyl; R is an optionally substituted C1-6alkyl or C1-6alkoxy group, aryl, heteroaryl, arylC1-4alkyl, heteroarylC1-4alkyl or a side-chain of a natural alpha -amino acid; R is hydrogen, C1-6alkyl, CHR COR (where R is a side-chain of a natural alpha -amino acid and R is hydroxyl, C1-6alkoxy or NHR where R represents a hydrogen atom or a C1-6alkyl group) or a group (CH2)nX (where n is 1 to 6 and X is hydroxyl, C1-4alkoxy, heteroaryl or a group NR R where R and R are each hydrogen or C1-6alkyl or the group NR R forms a 5 to 7 membered cyclic amine); and Het is an optionally substituted cyclic imide where the cyclic imide ring system has the formula (i), (ii) or (iii) in which A, B, C and D are each CH or 1 or 2 of A, B, C and D represents N and the others represent CH, and E and F may each independently represent CH or N; and physiologically acceptable salts and solvates thereof. These compounds inhibit metalloproteases involved in tissue degradation. Compounds of the invention may be formulated for use in a variety of conditions involving tissue degradation including arthropathy, dermatological conditions, bone resorption, inflammatory diseases, tumour invasion and multiple sclerosis and related diseases involving myelin degradation, and in the promotion of wound healing.

Patent Agency Ranking